Panchkula-based Venus Remedies has received its second PLI incentive payout for FY25, taking total disbursements to 75%. The release follows the company meeting investment, production, and sales targets under the scheme.
Akums Drugs secures EU GMP renewal for Plant 1 and first-time approval for Plant 2 in Haridwar, boosting its global CDMO presence in regulated pharma markets.
Corona Remedies Limited has secured the Eurasian Economic Union – Good Manufacturing Practices (EAEU–GMP) certification, marking a significant milestone in its global expansion. Announced on January 22, 2026, this certification allows the compa...
Max Institute of Laparoscopic Surgery, Robotic Surgery, Bariatric Surgery & GI Surgery has entered into a strategic Memorandum of Understanding (MoU) with Intuitive Surgical to accelerate the adoption of robotic-assisted surgery in India. The part...
AstraZeneca has acquired AbelZeta Pharma’s remaining China rights to the CAR-T therapy C-CAR031, gaining full global control while positioning the program for broader development in liver cancer and solid tumors.
Manthan 2026, a Research & Development Leadership Symposium, concluded successfully at Novotel, Mumbai. The insightful day-long symposium brought together eminent voices, leaders, and experts from across India’s life sciences and clinical...
Sun Pharmaceutical Industries has launched Unloxcyt in the United States following FDA approval of an updated label, expanding treatment options for patients with advanced cutaneous squamous cell carcinoma.
Max Healthcare has collaborated with Google to allow patients to book hospital appointments directly from Google Search and Maps, making access to verified care faster, simpler, and more reliable across India.
Boehringer Ingelheim has initiated a phase IIa clinical trial to evaluate BI 765423, a monoclonal antibody targeting interleukin-11 (IL-11), for the treatment of idiopathic pulmonary fibrosis (IPF). The study is part of the company’s ongoing resea...
As health-tech startups and pharmaceutical innovators drive rapid adoption of injectable weight-loss drugs, new UK research has raised questions about their durability as long-term obesity solutions. While medications such as semaglutide (Wegovy...
.jpg)
.jpg)
, CDSCO.jpg)